Publications by authors named "Michael Boxberger"

Claim this Profile
E
Efficacy and Safety of Polymer-Free Ultrathin Strut Sirolimus-Probucol Coated Drug-Eluting Stents for Chronic Total Occlusions: Insights from the Coroflex ISAR 2000 Worldwide Registry.
Ahmad Syadi Mahmood Zuhdi, Florian Krackhardt, Matthias W Waliszewski, Muhammad Dzafir Ismail, Michael Boxberger

Cardiol Res Pract· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymer-free sirolimus-eluting stents in a large-scale all-comers population.
Florian Krackhardt, Viktor Kočka, Matthias W Waliszewski, Andreas Utech, Meik Lustermann, Michael Boxberger

Open Heart· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The outcomes of patients with very small coronary artery disease treated with thin strut cobalt chromium bare metal stents: an observational study.
Muhammad Dzafir Ismail, Wan Azman Wan Ahmad, Matthias Leschke, Matthias Waliszewski, Michael Boxberger

Springerplus· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug eluting balloons as stand alone procedure for coronary bifurcational lesions: results of the randomized multicenter PEPCAD-BIF trial.
Franz X Kleber, Harald Rittger, Josef Ludwig, Antonia Schulz, Detlef G Mathey, Michael Boxberger

Clin Res Cardiol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of paclitaxel coated balloon (PCB) in acute coronary syndrome of small vessel de novo lesions: an analysis of a prospective 'real world' registry.
Ahmad Syadi Mahmood Zuhdi, Uwe Zeymer, Matthias Waliszewski, Martin Spiecker, Muhammad Dzafir Ismail, Michael Boxberger

Springerplus· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study.
Martin Unverdorben, Christian Vallbracht, Bodo Cremers, Hubertus Heuer, Christian Hengstenberg, Michael Boxberger

EuroIntervention· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The paclitaxel-eluting PTCA-balloon in combination with a cobalt-chromium stent in two different sequences to treat de novo coronary artery lesions: an angiographic follow up study.
Upendra Kaul, Martin Unverdorben, Ralf Degenhardt, Ashok Seth, Vinay K Bahl, Michael Boxberger

Indian Heart J· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stenting and Adjunctive Delivery of Paclitaxel Via Balloon Coating Versus Durable Polymeric Matrix for De Novo Coronary Lesions: Clinical and Angiographic Results from the Prospective Randomized Trial.
Aleksander Żurakowski, Piotr P Buszman, Krzysztof P Milewski, Adam Janas, Bogdan Gorycki, Michael Boxberger

J Interv Cardiol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of small coronary arteries with a paclitaxel-coated balloon catheter in the PEPCAD I study: are lesions clinically stable from 12 to 36 months?
Martin Unverdorben, Franz X Kleber, Hubertus Heuer, Hans-Reiner Figulla, Christian Vallbracht, Michael Boxberger

EuroIntervention· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of bifurcation lesions with a drug-eluting balloon: the PEPCAD V (Paclitaxel Eluting PTCA Balloon in Coronary Artery Disease) trial.
Detlef G Mathey, Imke Wendig, Michael Boxberger, Klaus Bonaventura, Franz X Kleber

EuroIntervention· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paclitaxel-eluting balloon angioplasty and cobalt-chromium stents versus conventional angioplasty and paclitaxel-eluting stents in the treatment of native coronary artery stenoses in patients with diabetes mellitus.
Rosli Mohd Ali, Ralf Degenhardt, Robaayah Zambahari, Damras Tresukosol, Wan Azman Wan Ahmad, Michael Boxberger

EuroIntervention· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The paclitaxel-eluting coroflex stent study II (PECOPS II) acute and 6-month clinical and angiographic follow-up, 1-year clinical follow-up.
Marcus Wiemer, Ralf Degenhardt, Christian Vallbracht, Dieter Horstkotte, Henrik Schneider, Michael Boxberger

J Interv Cardiol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of small coronary arteries with a paclitaxel-coated balloon catheter.
Martin Unverdorben, Franz X Kleber, Hubertus Heuer, Hans-Reiner Figulla, Christian Vallbracht, Michael Boxberger

Clin Res Cardiol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The paclitaxel-eluting Coroflex Please stent study (PECOPS I): the 3-year clinical follow-up.
Martin Unverdorben, Ralf Degenhardt, Marcus Wiemer, Dieter Horstkotte, Henrik Schneider, Michael Boxberger

Catheter Cardiovasc Interv· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis.
Martin Unverdorben, Christian Vallbracht, Bodo Cremers, Hubertus Heuer, Christian Hengstenberg, Michael Boxberger

Circulation· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short- and long-term effects of a novel paclitaxel coated stent in the porcine coronary model.
Bruno Scheller, Michael Kühler, Bodo Cremers, Dirk Mahnkopf, Michael Böhm, Michael Boxberger

Clin Res Cardiol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The paclitaxel-eluting Coroflex Please stent pilot study (PECOPS I) : the one-year clinical follow-up.
Martin Unverdorben, Ralf Degenhardt, Marcus Wiemer, Dieter Horstkotte, Henrik Schneider, Michael Boxberger

Clin Res Cardiol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The paclitaxel-eluting Coroflex Please stent pilot study (PECOPS I): acute and 6-month clinical and angiographic follow-up.
Martin Unverdorben, Ralf Degenhardt, Christian Vallbracht, Marcus Wiemer, Dieter Horstkotte, Michael Boxberger

Catheter Cardiovasc Interv· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis